Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Angelberger

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphyI Virgolini, A Kurtaran, M Leimer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal agingW Pirker, S Asenbaum, M Hauk, et al.
British Journal of Cancer|September 1, 1993
Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancerI Virgolini, G Kornek, J Höbart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphyM Raderer, A Becherer, A Kurtaran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancerM Raderer, A Kurtaran, Q Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteersI Virgolini, A Kurtaran, M Leimer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995
Characterization of LDL and VLDL binding sites on human basophils and mast cellsI Virgolini, S R Li, Q Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECTW Pirker, M Riedl, A Luger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998M Raderer, A Kurtaran, M Leimer, et al.
The New England Journal of Medicine|October 27, 1994
Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumorsI Virgolini, M Raderer, A Kurtaran, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphyI Virgolini, A Kurtaran, M Leimer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal agingW Pirker, S Asenbaum, M Hauk, et al.
British Journal of Cancer|September 1, 1993
Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancerI Virgolini, G Kornek, J Höbart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphyM Raderer, A Becherer, A Kurtaran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancerM Raderer, A Kurtaran, Q Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteersI Virgolini, A Kurtaran, M Leimer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995
Characterization of LDL and VLDL binding sites on human basophils and mast cellsI Virgolini, S R Li, Q Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECTW Pirker, M Riedl, A Luger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998M Raderer, A Kurtaran, M Leimer, et al.
The New England Journal of Medicine|October 27, 1994
Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumorsI Virgolini, M Raderer, A Kurtaran, et al.
Pageof 11